Stay-at-home trials are allowing more people to participate in test runs.
The past: Participants in drug trials previously had to spend a lot of time and money visiting research locations. That hassle contributes to a 30 percent dropout rate.
The future: Virtual trials have people do the work and testing themselves. “Because we bring trials to patients in their homes, we remove barriers, whether geography or time and inconvenience, that are preventing them from participating,” Belinda Tan, cofounder of Science 37, told Undark. A recent trial by AOBiome Therapeutics of an acne medication recruited people through social media, screened 8,000 candidates online, and conducted the research through traditional mail, e-mail, iPhone app, and videoconferencing.
Ups and downs: While virtual trials are cheaper and more convenient, it does make it harder to ensure that some tests are done consistently and properly, since many people don’t like injecting themselves.
This story first appeared in our daily tech newsletter, The Download. You can sign up here.
Biotechnology and health
The Biggest Questions: What is death?
New neuroscience is challenging our understanding of the dying process—bringing opportunities for the living.
Some deaf children in China can hear after gene therapy treatment
After deafness treatment, Yiyi can hear her mother and dance to the music. But why is it so noisy at night?
Scientists just drafted an incredibly detailed map of the human brain
A massive suite of papers offers a high-res view of the human and non-human primate brain.
I received the new gene-editing drug for sickle cell disease. It changed my life.
As a patient enrolled in a clinical trial for Vertex’s new exa-cel treatment, I was among the first to experience CRISPR’s transformative effects.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.